loadpatents
Patent applications and USPTO patent grants for Metobo; Samuel E..The latest application filed is for "toll like receptor modulator compounds".
Patent | Date |
---|---|
Substituted eneoxindoles and uses thereof Grant 11,453,681 - Aktoudianakis , et al. September 27, 2 | 2022-09-27 |
Toll Like Receptor Modulator Compounds App 20220218709 - Aktoudianakis; Evangelos ;   et al. | 2022-07-14 |
PD-1/PD-L1 inhibitors Grant 11,236,085 - Du , et al. February 1, 2 | 2022-02-01 |
Processes And Intermediates For The Preparation Of 1`-substituted Carba-nucleoside Analogs App 20210403497 - Butler; Thomas ;   et al. | 2021-12-30 |
Pd-1/pd-l1 Inhibitors App 20210323922 - Aktoudianakis; Evangelos ;   et al. | 2021-10-21 |
Antiviral Pyrazolopyridinone Compounds App 20210130302 - KONST; Zef ;   et al. | 2021-05-06 |
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs Grant 10,988,498 - Butler , et al. April 27, 2 | 2021-04-27 |
Pd-1/pd-l1 Inhibitors App 20210053946 - Aktoudianakis; Evangelos ;   et al. | 2021-02-25 |
Pd-1/pd-l1 Inhibitors App 20210024494 - Aktoudianakis; Evangelos ;   et al. | 2021-01-28 |
PD-1/PD-L1 inhibitors Grant 10,899,735 - Aktoudianakis , et al. January 26, 2 | 2021-01-26 |
Processes For Preparing Toll-like Receptor Modulator Compounds App 20210017170 - Aktoudianakis; Evangelos ;   et al. | 2021-01-21 |
Substituted Eneoxindoles And Uses Thereof App 20200392153 - Aktoudianakis; Evangelos ;   et al. | 2020-12-17 |
PD-1/PD-L1 inhibitors Grant 10,774,071 - Aktoudianakis , et al. September 15, 2 | 2020-09-15 |
PD-1/PD-L1 inhibitors Grant 10,710,986 - Aktoudianakis , et al. | 2020-07-14 |
Pd-1/pd-l1 Inhibitors App 20200157094 - Du; Zhimin ;   et al. | 2020-05-21 |
Pd-1/pd-l1 Inhibitors App 20200017471 - Aktoudianakis; Evangelos ;   et al. | 2020-01-16 |
Pd-1/pd-l1 Inhibitors App 20190345131 - AKTOUDIANAKIS; Evangelos ;   et al. | 2019-11-14 |
Compounds for the treatment of hepatitis B virus infection Grant 10,442,804 - Aktoudianakis , et al. Oc | 2019-10-15 |
Toll Like Receptor Modulator Compounds App 20190282576 - Aktoudianakis; Evangelos ;   et al. | 2019-09-19 |
Pd-1/pd-l1 Inhibitors App 20190270727 - Aktoudianakis; Evangelos ;   et al. | 2019-09-05 |
Toll like receptor modulator compounds Grant 10,285,990 - Aktoudianakis , et al. | 2019-05-14 |
Processes And Intermediates For The Preparation Of 1'-substituted Carba-nucleoside Analogs App 20180327437 - Butler; Thomas ;   et al. | 2018-11-15 |
Pd-1/pd-l1 Inhibitors App 20180305315 - Aktoudianakis; Evangelos ;   et al. | 2018-10-25 |
Benzimidazole Derivatives As Bromodomain Inhibitors App 20180282316 - Aktoudianakis; Evangelos ;   et al. | 2018-10-04 |
Compounds For The Treatment Of Hepatitis B Virus Infection App 20180251460 - Aktoudianakis; Evangelos ;   et al. | 2018-09-06 |
Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs Grant 10,023,600 - Butler , et al. July 17, 2 | 2018-07-17 |
Compounds For The Treatment Of Hepatitis B Virus Infection App 20170342068 - Aktoudianakis; Evangelos ;   et al. | 2017-11-30 |
Toll Like Receptor Modulator Compounds App 20170281627 - Aktoudianakis; Evangelos ;   et al. | 2017-10-05 |
Toll like receptor modulator compounds Grant 9,670,205 - Aktoudianakis , et al. June 6, 2 | 2017-06-06 |
Benzimidazole Derivatives As Bromodomain Inhibitors App 20160376261 - Aktoudianakis; Evangelos ;   et al. | 2016-12-29 |
Toll Like Receptor Modulator Compounds App 20160289229 - Aktoudianakis; Evangelos ;   et al. | 2016-10-06 |
Benzimidazole derivatives as bromodomain inhibitors Grant 9,458,145 - Aktoudianakis , et al. October 4, 2 | 2016-10-04 |
Benzimidazole Derivatives As Bromodomain Inhibitors App 20160075695 - Aktoudianakis; Evangelos ;   et al. | 2016-03-17 |
Benzimidazolone derivatives as bromodomain inhibitors Grant 9,255,089 - Aktoudianakis , et al. February 9, 2 | 2016-02-09 |
Benzimidazolone Derivatives As Bromodomain Inhibitors App 20160031868 - Aktoudianakis; Evangelos ;   et al. | 2016-02-04 |
Benzimidazole Derivatives As Bromodomain Inhibitors App 20140336190 - Aktoudianakis; Evangelos ;   et al. | 2014-11-13 |
Benzimidazolone Derivatives As Bromodomain Inhibitors App 20140296246 - Aktoudianakis; Evangelos ;   et al. | 2014-10-02 |
Processes And Intermediates For The Preparation Of 1'-substituted Carba-nucleoside Analogs App 20110230654 - Butler; Thomas ;   et al. | 2011-09-22 |
Integrase inhibitors Grant 8,008,287 - Cai , et al. August 30, 2 | 2011-08-30 |
Antiviral compounds Grant 7,998,950 - Aktoudianakis , et al. August 16, 2 | 2011-08-16 |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment Grant 7,973,013 - Cho , et al. July 5, 2 | 2011-07-05 |
2'-fluoro Substituted Carba-nucleoside Analogs For Antiviral Treatment App 20110070194 - Cho; Aesop ;   et al. | 2011-03-24 |
Antiviral Compounds App 20100022508 - Aktoudianakis; Evangelos ;   et al. | 2010-01-28 |
Integrase Inhibitors App 20090306054 - Cai; Zhenhong R. ;   et al. | 2009-12-10 |
Integrase Inhibitors App 20090291921 - Jabri; Salman Y. ;   et al. | 2009-11-26 |
Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds App 20080076738 - Cai; Zhenhong R. ;   et al. | 2008-03-27 |
Antiviral compounds App 20080076740 - Cai; Zhenhong R. ;   et al. | 2008-03-27 |
Integrase inhibitors App 20080058315 - Cai; Zhenhong R. ;   et al. | 2008-03-06 |
Integrase inhibitor compounds App 20070072831 - Cai; Zhenhong R. ;   et al. | 2007-03-29 |
Phosphonate analogs of HIV integrase inhibitor compounds App 20060116356 - Cai; Zhenhong R. ;   et al. | 2006-06-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.